Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pancreatitis, Chronic | 25 | 2019 | 168 | 6.550 |
Why?
|
Pancreatectomy | 28 | 2021 | 129 | 5.800 |
Why?
|
Islets of Langerhans Transplantation | 16 | 2021 | 101 | 4.270 |
Why?
|
Pancreaticojejunostomy | 15 | 2021 | 21 | 2.900 |
Why?
|
Pancreatic Neoplasms | 15 | 2016 | 332 | 2.400 |
Why?
|
Pancreatitis | 22 | 2017 | 279 | 2.180 |
Why?
|
Pancreaticoduodenectomy | 10 | 2021 | 34 | 1.770 |
Why?
|
Cholecystectomy, Laparoscopic | 8 | 2013 | 59 | 1.330 |
Why?
|
Pancreas | 11 | 2021 | 225 | 1.300 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 18 | 2019 | 348 | 1.300 |
Why?
|
Postoperative Complications | 18 | 2017 | 1615 | 1.260 |
Why?
|
Pancreatic Fistula | 7 | 2021 | 23 | 1.180 |
Why?
|
Pancreatic Pseudocyst | 9 | 2010 | 24 | 1.130 |
Why?
|
Islets of Langerhans | 7 | 2021 | 87 | 1.130 |
Why?
|
Pancreatic Diseases | 4 | 2016 | 66 | 0.930 |
Why?
|
Treatment Outcome | 28 | 2019 | 7029 | 0.920 |
Why?
|
Patient Selection | 3 | 2017 | 592 | 0.920 |
Why?
|
Retrospective Studies | 40 | 2021 | 7277 | 0.890 |
Why?
|
Surgeons | 2 | 2021 | 68 | 0.870 |
Why?
|
Intraoperative Complications | 5 | 2012 | 129 | 0.860 |
Why?
|
Humans | 107 | 2021 | 68618 | 0.840 |
Why?
|
Adult | 61 | 2021 | 21403 | 0.830 |
Why?
|
Middle Aged | 54 | 2019 | 21147 | 0.830 |
Why?
|
Drainage | 10 | 2017 | 133 | 0.820 |
Why?
|
Transplantation, Autologous | 9 | 2021 | 145 | 0.810 |
Why?
|
Pancreatic Ducts | 4 | 2012 | 76 | 0.800 |
Why?
|
Reoperation | 11 | 2013 | 467 | 0.800 |
Why?
|
Female | 73 | 2021 | 38074 | 0.790 |
Why?
|
Quality of Life | 8 | 2019 | 1515 | 0.770 |
Why?
|
Male | 74 | 2021 | 37321 | 0.770 |
Why?
|
Cystadenoma, Mucinous | 2 | 2010 | 7 | 0.730 |
Why?
|
Anastomosis, Surgical | 5 | 2015 | 104 | 0.660 |
Why?
|
Autoimmune Diseases | 3 | 2010 | 186 | 0.650 |
Why?
|
Traumatology | 1 | 2018 | 20 | 0.630 |
Why?
|
Adenocarcinoma | 4 | 2010 | 475 | 0.610 |
Why?
|
Sphincter of Oddi Dysfunction | 2 | 2009 | 48 | 0.610 |
Why?
|
Length of Stay | 10 | 2019 | 780 | 0.610 |
Why?
|
Gastric Bypass | 2 | 2009 | 83 | 0.600 |
Why?
|
Abdominal Injuries | 5 | 2010 | 60 | 0.590 |
Why?
|
Pain, Intractable | 3 | 2013 | 28 | 0.580 |
Why?
|
Obesity, Morbid | 2 | 2009 | 172 | 0.550 |
Why?
|
Aged | 35 | 2019 | 14862 | 0.530 |
Why?
|
Paraganglioma | 1 | 2015 | 8 | 0.530 |
Why?
|
Ampulla of Vater | 1 | 2015 | 34 | 0.520 |
Why?
|
Lymphatic Metastasis | 2 | 2016 | 274 | 0.520 |
Why?
|
Insulin | 5 | 2019 | 619 | 0.520 |
Why?
|
Sphincterotomy, Transduodenal | 3 | 2013 | 24 | 0.500 |
Why?
|
Bile Ducts | 2 | 2012 | 59 | 0.500 |
Why?
|
Clinical Protocols | 1 | 2016 | 172 | 0.500 |
Why?
|
Perioperative Care | 1 | 2016 | 100 | 0.500 |
Why?
|
Neuroendocrine Tumors | 2 | 2016 | 10 | 0.490 |
Why?
|
Follow-Up Studies | 15 | 2017 | 3259 | 0.490 |
Why?
|
Elective Surgical Procedures | 3 | 2016 | 95 | 0.480 |
Why?
|
Biliary Dyskinesia | 1 | 2013 | 7 | 0.450 |
Why?
|
Common Bile Duct | 2 | 2011 | 22 | 0.440 |
Why?
|
Bacterial Infections | 2 | 2013 | 163 | 0.430 |
Why?
|
Health Services | 1 | 2013 | 87 | 0.420 |
Why?
|
Psychometrics | 1 | 2015 | 514 | 0.410 |
Why?
|
Gallbladder Diseases | 1 | 2012 | 16 | 0.400 |
Why?
|
Cooperative Behavior | 1 | 2013 | 235 | 0.400 |
Why?
|
Interprofessional Relations | 1 | 2013 | 188 | 0.400 |
Why?
|
Pain Management | 1 | 2013 | 186 | 0.390 |
Why?
|
Value of Life | 1 | 2011 | 14 | 0.380 |
Why?
|
Quality-Adjusted Life Years | 1 | 2011 | 106 | 0.370 |
Why?
|
Adolescent | 18 | 2019 | 8912 | 0.360 |
Why?
|
Cholestasis | 2 | 2009 | 90 | 0.360 |
Why?
|
Enteral Nutrition | 2 | 2007 | 157 | 0.350 |
Why?
|
Risk Management | 1 | 2010 | 37 | 0.350 |
Why?
|
Laparotomy | 1 | 2010 | 65 | 0.350 |
Why?
|
Endosonography | 5 | 2010 | 177 | 0.350 |
Why?
|
Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2010 | 22 | 0.350 |
Why?
|
Analgesics, Opioid | 2 | 2012 | 498 | 0.340 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2010 | 46 | 0.340 |
Why?
|
Gastrectomy | 1 | 2009 | 24 | 0.340 |
Why?
|
Peptic Ulcer | 1 | 2009 | 37 | 0.340 |
Why?
|
Intestinal Perforation | 1 | 2009 | 35 | 0.330 |
Why?
|
Wounds, Nonpenetrating | 1 | 2010 | 131 | 0.320 |
Why?
|
Pancreatitis, Alcoholic | 1 | 2008 | 11 | 0.310 |
Why?
|
Chronic Disease | 16 | 2008 | 1330 | 0.310 |
Why?
|
Digestive System Abnormalities | 1 | 2008 | 7 | 0.310 |
Why?
|
Digestive System Surgical Procedures | 3 | 2008 | 30 | 0.310 |
Why?
|
Intubation, Gastrointestinal | 1 | 2007 | 48 | 0.300 |
Why?
|
Splenectomy | 4 | 2010 | 40 | 0.290 |
Why?
|
Colonic Neoplasms | 1 | 2010 | 299 | 0.290 |
Why?
|
Cholecystectomy | 4 | 2017 | 79 | 0.290 |
Why?
|
Mesenchymal Stem Cell Transplantation | 2 | 2017 | 63 | 0.280 |
Why?
|
Tomography, X-Ray Computed | 14 | 2011 | 2324 | 0.280 |
Why?
|
Diabetes Mellitus | 2 | 2017 | 694 | 0.280 |
Why?
|
Liver Cirrhosis | 1 | 2010 | 301 | 0.270 |
Why?
|
Cholelithiasis | 3 | 1998 | 66 | 0.270 |
Why?
|
Preoperative Care | 4 | 2010 | 275 | 0.270 |
Why?
|
Adipose Tissue | 2 | 2017 | 221 | 0.270 |
Why?
|
Stents | 4 | 2008 | 657 | 0.270 |
Why?
|
Warfare | 3 | 2010 | 58 | 0.270 |
Why?
|
Chi-Square Distribution | 4 | 2008 | 546 | 0.260 |
Why?
|
Protein-Energy Malnutrition | 1 | 2005 | 4 | 0.260 |
Why?
|
Survival Rate | 6 | 2017 | 1056 | 0.250 |
Why?
|
Diagnosis, Differential | 5 | 2013 | 1140 | 0.250 |
Why?
|
South Carolina | 5 | 2018 | 2752 | 0.250 |
Why?
|
Bilirubin | 2 | 2015 | 51 | 0.240 |
Why?
|
Catheterization | 4 | 2000 | 209 | 0.240 |
Why?
|
Lithotripsy | 2 | 2001 | 18 | 0.230 |
Why?
|
Risk Assessment | 7 | 2011 | 2007 | 0.230 |
Why?
|
History, 20th Century | 5 | 2018 | 248 | 0.220 |
Why?
|
Pancreas Transplantation | 2 | 2012 | 71 | 0.220 |
Why?
|
Intestinal Fistula | 3 | 1994 | 26 | 0.210 |
Why?
|
Young Adult | 5 | 2016 | 5717 | 0.200 |
Why?
|
Licensure, Medical | 1 | 2021 | 12 | 0.200 |
Why?
|
Colonic Diseases | 2 | 1994 | 36 | 0.190 |
Why?
|
Choledochostomy | 2 | 2011 | 10 | 0.180 |
Why?
|
General Surgery | 3 | 2021 | 95 | 0.180 |
Why?
|
Risk Factors | 6 | 2017 | 5731 | 0.180 |
Why?
|
Wounds, Penetrating | 2 | 2010 | 45 | 0.180 |
Why?
|
Regression Analysis | 3 | 2007 | 737 | 0.180 |
Why?
|
Hemorrhage | 2 | 1993 | 328 | 0.170 |
Why?
|
Educational Measurement | 1 | 2021 | 254 | 0.170 |
Why?
|
Carbon Monoxide | 1 | 2019 | 58 | 0.170 |
Why?
|
Blood Glucose | 4 | 2017 | 631 | 0.170 |
Why?
|
Students, Medical | 1 | 2021 | 210 | 0.160 |
Why?
|
Cytokines | 3 | 2019 | 866 | 0.160 |
Why?
|
Mississippi | 1 | 2018 | 11 | 0.160 |
Why?
|
Ohio | 1 | 2018 | 64 | 0.160 |
Why?
|
Magnetic Resonance Imaging | 4 | 2011 | 2223 | 0.160 |
Why?
|
Carcinoma, Papillary | 2 | 2015 | 35 | 0.160 |
Why?
|
Surveys and Questionnaires | 3 | 2019 | 2800 | 0.150 |
Why?
|
Cholangitis | 1 | 2017 | 15 | 0.150 |
Why?
|
Recurrence | 4 | 2017 | 948 | 0.150 |
Why?
|
Cell- and Tissue-Based Therapy | 1 | 2017 | 35 | 0.150 |
Why?
|
Severity of Illness Index | 4 | 2007 | 1851 | 0.150 |
Why?
|
Prognosis | 3 | 2016 | 2093 | 0.140 |
Why?
|
Sphincterotomy, Endoscopic | 1 | 2017 | 79 | 0.140 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2017 | 48 | 0.140 |
Why?
|
Insulin-Secreting Cells | 1 | 2017 | 41 | 0.140 |
Why?
|
Jejunostomy | 2 | 2000 | 26 | 0.140 |
Why?
|
alpha 1-Antitrypsin | 1 | 2017 | 61 | 0.140 |
Why?
|
Graft Survival | 2 | 2017 | 465 | 0.140 |
Why?
|
Lymph Node Excision | 1 | 2016 | 91 | 0.140 |
Why?
|
Cell-Penetrating Peptides | 1 | 2016 | 8 | 0.130 |
Why?
|
Cell Membrane Permeability | 1 | 2016 | 59 | 0.130 |
Why?
|
MicroRNAs | 1 | 2021 | 447 | 0.130 |
Why?
|
Stem Cells | 1 | 2017 | 248 | 0.130 |
Why?
|
Allografts | 1 | 2016 | 63 | 0.130 |
Why?
|
Nutritional Status | 2 | 2007 | 112 | 0.130 |
Why?
|
Insulin Resistance | 2 | 2015 | 241 | 0.130 |
Why?
|
Octreotide | 4 | 2007 | 21 | 0.130 |
Why?
|
Adipokines | 1 | 2015 | 20 | 0.130 |
Why?
|
Lymph Nodes | 1 | 2016 | 258 | 0.130 |
Why?
|
Toll-Like Receptor 4 | 1 | 2016 | 114 | 0.130 |
Why?
|
Anastomosis, Roux-en-Y | 2 | 2008 | 15 | 0.120 |
Why?
|
Hospital Costs | 1 | 2016 | 117 | 0.120 |
Why?
|
Cohort Studies | 3 | 2017 | 2358 | 0.120 |
Why?
|
Prospective Studies | 4 | 2021 | 3705 | 0.120 |
Why?
|
Laparoscopy | 4 | 2010 | 237 | 0.120 |
Why?
|
Mice, Inbred C57BL | 6 | 2017 | 2791 | 0.120 |
Why?
|
Diabetes Mellitus, Experimental | 1 | 2017 | 195 | 0.120 |
Why?
|
PPAR gamma | 1 | 2015 | 95 | 0.120 |
Why?
|
Gastrostomy | 1 | 2015 | 110 | 0.120 |
Why?
|
Reference Values | 2 | 2005 | 579 | 0.120 |
Why?
|
Postoperative Period | 1 | 2015 | 238 | 0.120 |
Why?
|
Inflammation | 3 | 2017 | 1030 | 0.120 |
Why?
|
Receptors, Leptin | 1 | 2014 | 6 | 0.120 |
Why?
|
Time Factors | 5 | 2019 | 4655 | 0.120 |
Why?
|
Fat Necrosis | 1 | 1993 | 2 | 0.120 |
Why?
|
Autografts | 1 | 2013 | 22 | 0.120 |
Why?
|
Wounds, Stab | 1 | 1993 | 7 | 0.120 |
Why?
|
Splenic Vein | 2 | 1990 | 4 | 0.110 |
Why?
|
Diagnosis-Related Groups | 1 | 2013 | 28 | 0.110 |
Why?
|
Cholesterol | 1 | 2015 | 331 | 0.110 |
Why?
|
Gallstones | 2 | 2007 | 58 | 0.110 |
Why?
|
Biliary Tract | 1 | 1993 | 17 | 0.110 |
Why?
|
Antibiotic Prophylaxis | 1 | 2013 | 62 | 0.110 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2014 | 99 | 0.110 |
Why?
|
Apoptosis | 2 | 2017 | 1641 | 0.110 |
Why?
|
Incidence | 2 | 2009 | 1603 | 0.110 |
Why?
|
United States | 6 | 2021 | 7367 | 0.110 |
Why?
|
Tissue and Organ Harvesting | 1 | 2013 | 49 | 0.110 |
Why?
|
Dilatation, Pathologic | 1 | 2012 | 58 | 0.110 |
Why?
|
Nanomedicine | 1 | 2012 | 19 | 0.110 |
Why?
|
Major Histocompatibility Complex | 1 | 2012 | 34 | 0.110 |
Why?
|
Leg | 1 | 1993 | 191 | 0.100 |
Why?
|
Glucose Tolerance Test | 3 | 2019 | 75 | 0.100 |
Why?
|
Recovery of Function | 1 | 2016 | 506 | 0.100 |
Why?
|
Angiography | 1 | 1993 | 194 | 0.100 |
Why?
|
Ureteral Diseases | 1 | 1991 | 5 | 0.100 |
Why?
|
Urinary Fistula | 1 | 1991 | 7 | 0.100 |
Why?
|
Urinary Bladder Fistula | 1 | 1991 | 9 | 0.100 |
Why?
|
Cysts | 2 | 2011 | 70 | 0.100 |
Why?
|
Polyethylene Glycols | 1 | 2012 | 149 | 0.100 |
Why?
|
Sacrococcygeal Region | 1 | 2011 | 4 | 0.100 |
Why?
|
Ascites | 2 | 2007 | 38 | 0.100 |
Why?
|
Blast Injuries | 2 | 2010 | 15 | 0.100 |
Why?
|
Rectal Diseases | 1 | 2011 | 13 | 0.100 |
Why?
|
Academic Medical Centers | 1 | 2013 | 281 | 0.100 |
Why?
|
Hamartoma | 1 | 2011 | 24 | 0.100 |
Why?
|
Freedom | 1 | 2011 | 9 | 0.100 |
Why?
|
Cholestasis, Extrahepatic | 1 | 2011 | 14 | 0.100 |
Why?
|
Duodenal Diseases | 2 | 1991 | 15 | 0.100 |
Why?
|
Colonoscopy | 2 | 1991 | 156 | 0.090 |
Why?
|
Patient Readmission | 1 | 2013 | 267 | 0.090 |
Why?
|
Abscess | 1 | 1990 | 37 | 0.090 |
Why?
|
Splenic Artery | 1 | 1990 | 16 | 0.090 |
Why?
|
Sclerosis | 1 | 2010 | 32 | 0.090 |
Why?
|
Vipoma | 1 | 2010 | 2 | 0.090 |
Why?
|
Gastrinoma | 1 | 2010 | 2 | 0.090 |
Why?
|
Somatostatinoma | 1 | 2010 | 3 | 0.090 |
Why?
|
Insulinoma | 1 | 2010 | 4 | 0.090 |
Why?
|
Glucagonoma | 1 | 2010 | 3 | 0.090 |
Why?
|
Catheterization, Peripheral | 1 | 1990 | 38 | 0.090 |
Why?
|
Jejunum | 1 | 2010 | 26 | 0.090 |
Why?
|
Carcinoma, Neuroendocrine | 1 | 2010 | 13 | 0.090 |
Why?
|
Constriction, Pathologic | 2 | 2010 | 236 | 0.090 |
Why?
|
Anemia, Sickle Cell | 1 | 1994 | 364 | 0.090 |
Why?
|
Surgical Staplers | 1 | 1989 | 4 | 0.090 |
Why?
|
Cholangiopancreatography, Magnetic Resonance | 1 | 2010 | 20 | 0.090 |
Why?
|
Obesity | 2 | 2015 | 1076 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 369 | 0.090 |
Why?
|
History, 19th Century | 3 | 2008 | 95 | 0.090 |
Why?
|
Child | 6 | 2015 | 6405 | 0.090 |
Why?
|
Rectum | 1 | 1989 | 62 | 0.090 |
Why?
|
Endoscopy | 2 | 1998 | 464 | 0.080 |
Why?
|
Carcinoma, Renal Cell | 1 | 2010 | 110 | 0.080 |
Why?
|
Iatrogenic Disease | 1 | 2009 | 36 | 0.080 |
Why?
|
Disease-Free Survival | 1 | 2010 | 349 | 0.080 |
Why?
|
Mice | 6 | 2017 | 8474 | 0.080 |
Why?
|
Feasibility Studies | 1 | 2011 | 652 | 0.080 |
Why?
|
Suture Techniques | 1 | 2009 | 75 | 0.080 |
Why?
|
Kidney Neoplasms | 1 | 2010 | 206 | 0.080 |
Why?
|
Cost-Benefit Analysis | 1 | 2011 | 504 | 0.080 |
Why?
|
Colon | 1 | 1989 | 168 | 0.080 |
Why?
|
Vaginal Fistula | 1 | 1988 | 3 | 0.080 |
Why?
|
Survivors | 1 | 2011 | 256 | 0.080 |
Why?
|
Colposcopy | 1 | 1988 | 20 | 0.080 |
Why?
|
Explosions | 1 | 1988 | 4 | 0.080 |
Why?
|
Fibrin Tissue Adhesive | 1 | 2007 | 17 | 0.080 |
Why?
|
Combined Modality Therapy | 2 | 2019 | 951 | 0.080 |
Why?
|
Nutritional Support | 1 | 2007 | 22 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2009 | 931 | 0.070 |
Why?
|
Adaptation, Psychological | 1 | 2011 | 447 | 0.070 |
Why?
|
Gastrointestinal Agents | 1 | 2007 | 51 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2010 | 334 | 0.070 |
Why?
|
Age Factors | 2 | 2016 | 1864 | 0.070 |
Why?
|
Immunohistochemistry | 4 | 2012 | 1174 | 0.070 |
Why?
|
Coculture Techniques | 2 | 2017 | 147 | 0.070 |
Why?
|
Pleural Effusion | 1 | 2007 | 74 | 0.070 |
Why?
|
Safety | 2 | 2006 | 145 | 0.070 |
Why?
|
Animals | 8 | 2017 | 20881 | 0.070 |
Why?
|
Duodenum | 1 | 1986 | 47 | 0.070 |
Why?
|
Cause of Death | 2 | 2006 | 241 | 0.070 |
Why?
|
Anti-Bacterial Agents | 1 | 2013 | 1026 | 0.070 |
Why?
|
Military Medicine | 2 | 1988 | 53 | 0.070 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2007 | 38 | 0.070 |
Why?
|
Diverticulum | 1 | 1986 | 29 | 0.070 |
Why?
|
Abdominal Abscess | 1 | 2006 | 8 | 0.070 |
Why?
|
Kidney Transplantation | 1 | 1994 | 839 | 0.070 |
Why?
|
Signal Transduction | 1 | 2016 | 2689 | 0.070 |
Why?
|
Foreign Bodies | 1 | 1986 | 58 | 0.070 |
Why?
|
Pancreatic Function Tests | 1 | 2005 | 6 | 0.070 |
Why?
|
Salvage Therapy | 1 | 2006 | 82 | 0.070 |
Why?
|
Cardiac Pacing, Artificial | 1 | 2007 | 174 | 0.070 |
Why?
|
Morbidity | 1 | 2005 | 130 | 0.060 |
Why?
|
Cell Death | 2 | 2017 | 329 | 0.060 |
Why?
|
Sex Distribution | 1 | 2005 | 274 | 0.060 |
Why?
|
Age Distribution | 1 | 2005 | 320 | 0.060 |
Why?
|
Mice, Obese | 2 | 2015 | 33 | 0.060 |
Why?
|
Probability | 1 | 2005 | 245 | 0.060 |
Why?
|
Digestive System | 1 | 2004 | 35 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2017 | 626 | 0.060 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2007 | 277 | 0.060 |
Why?
|
Leptin | 2 | 2015 | 80 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2004 | 120 | 0.060 |
Why?
|
Heart Diseases | 1 | 2006 | 276 | 0.060 |
Why?
|
Critical Care | 1 | 2006 | 263 | 0.060 |
Why?
|
Lipoproteins | 1 | 2004 | 161 | 0.060 |
Why?
|
Austria | 1 | 2003 | 17 | 0.060 |
Why?
|
Health Status | 1 | 2006 | 429 | 0.060 |
Why?
|
Macrophages | 2 | 2017 | 647 | 0.050 |
Why?
|
Wounds, Gunshot | 1 | 1983 | 48 | 0.050 |
Why?
|
Body Weight | 2 | 2015 | 554 | 0.050 |
Why?
|
Treatment Failure | 2 | 2000 | 216 | 0.050 |
Why?
|
Liver | 3 | 2015 | 1118 | 0.050 |
Why?
|
Multivariate Analysis | 1 | 2005 | 1046 | 0.050 |
Why?
|
Job Application | 1 | 2021 | 3 | 0.050 |
Why?
|
Governing Board | 1 | 2021 | 12 | 0.050 |
Why?
|
Lithiasis | 1 | 2001 | 2 | 0.050 |
Why?
|
Intraoperative Period | 1 | 2001 | 62 | 0.050 |
Why?
|
Case-Control Studies | 1 | 2005 | 1553 | 0.050 |
Why?
|
Self-Assessment | 1 | 2001 | 69 | 0.050 |
Why?
|
Cholangiography | 3 | 1998 | 55 | 0.040 |
Why?
|
Chemokines, CC | 1 | 2019 | 18 | 0.040 |
Why?
|
Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
Chemokine CXCL12 | 1 | 2019 | 51 | 0.040 |
Why?
|
Geography | 1 | 2019 | 80 | 0.040 |
Why?
|
Hemostatics | 1 | 1999 | 47 | 0.040 |
Why?
|
Acetylglucosamine | 1 | 1999 | 46 | 0.040 |
Why?
|
DNA Methylation | 1 | 2019 | 193 | 0.040 |
Why?
|
Cholecystitis | 1 | 1998 | 12 | 0.040 |
Why?
|
Triage | 2 | 1990 | 109 | 0.040 |
Why?
|
Tissue Survival | 1 | 2017 | 22 | 0.040 |
Why?
|
Ceruletide | 1 | 2017 | 8 | 0.040 |
Why?
|
Acinar Cells | 1 | 2017 | 8 | 0.040 |
Why?
|
Amylases | 1 | 2017 | 17 | 0.040 |
Why?
|
Multiple Chronic Conditions | 1 | 2017 | 9 | 0.040 |
Why?
|
Paracrine Communication | 1 | 2017 | 31 | 0.040 |
Why?
|
Polysaccharides | 1 | 1999 | 176 | 0.040 |
Why?
|
Choledocholithiasis | 1 | 2017 | 14 | 0.040 |
Why?
|
Culture Media, Conditioned | 1 | 2017 | 78 | 0.040 |
Why?
|
Patient Outcome Assessment | 1 | 2017 | 42 | 0.040 |
Why?
|
Stem Cell Transplantation | 1 | 2017 | 58 | 0.040 |
Why?
|
Risk Adjustment | 1 | 2017 | 49 | 0.040 |
Why?
|
Propensity Score | 1 | 2017 | 117 | 0.040 |
Why?
|
Mice, Inbred NOD | 1 | 2017 | 138 | 0.040 |
Why?
|
Genes, Reporter | 1 | 2017 | 191 | 0.040 |
Why?
|
Antithrombin III | 1 | 2017 | 23 | 0.040 |
Why?
|
Tissue Donors | 1 | 2019 | 195 | 0.040 |
Why?
|
Pilot Projects | 2 | 2017 | 1342 | 0.040 |
Why?
|
Thromboplastin | 1 | 2017 | 21 | 0.040 |
Why?
|
Green Fluorescent Proteins | 1 | 2017 | 200 | 0.040 |
Why?
|
Mice, SCID | 1 | 2017 | 238 | 0.040 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2017 | 110 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2017 | 82 | 0.040 |
Why?
|
Transplantation, Heterologous | 1 | 2017 | 122 | 0.030 |
Why?
|
Fibrinogen | 1 | 2017 | 87 | 0.030 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2017 | 140 | 0.030 |
Why?
|
Neoplasm Grading | 1 | 2016 | 111 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2017 | 242 | 0.030 |
Why?
|
Tumor Burden | 1 | 2016 | 132 | 0.030 |
Why?
|
Histocompatibility Antigens | 1 | 2016 | 12 | 0.030 |
Why?
|
SEER Program | 1 | 2016 | 153 | 0.030 |
Why?
|
Sensitivity and Specificity | 3 | 2007 | 1753 | 0.030 |
Why?
|
RAW 264.7 Cells | 1 | 2016 | 42 | 0.030 |
Why?
|
Cytoprotection | 1 | 2016 | 39 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2017 | 244 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2017 | 330 | 0.030 |
Why?
|
Palliative Care | 1 | 1998 | 271 | 0.030 |
Why?
|
Protein Domains | 1 | 2016 | 74 | 0.030 |
Why?
|
Cell Hypoxia | 1 | 2016 | 92 | 0.030 |
Why?
|
Internship and Residency | 1 | 2021 | 596 | 0.030 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2015 | 9 | 0.030 |
Why?
|
Adiponectin | 1 | 2015 | 52 | 0.030 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 498 | 0.030 |
Why?
|
Receptor, Insulin | 1 | 2015 | 71 | 0.030 |
Why?
|
Diet, High-Fat | 1 | 2015 | 81 | 0.030 |
Why?
|
Logistic Models | 1 | 2019 | 1420 | 0.030 |
Why?
|
Gene Expression | 1 | 2017 | 770 | 0.030 |
Why?
|
NF-kappa B | 1 | 2017 | 432 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2016 | 532 | 0.030 |
Why?
|
Cell Movement | 1 | 2017 | 630 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2019 | 1174 | 0.030 |
Why?
|
Biopsy, Needle | 2 | 2011 | 191 | 0.030 |
Why?
|
Acute Disease | 2 | 1994 | 658 | 0.030 |
Why?
|
Equipment Failure | 2 | 1993 | 112 | 0.030 |
Why?
|
Biliary Fistula | 1 | 1994 | 3 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2015 | 186 | 0.030 |
Why?
|
Neoplasm Staging | 1 | 2016 | 800 | 0.030 |
Why?
|
Colostomy | 1 | 1994 | 15 | 0.030 |
Why?
|
Protein Denaturation | 1 | 2014 | 27 | 0.030 |
Why?
|
Cutaneous Fistula | 1 | 1994 | 11 | 0.030 |
Why?
|
Pheochromocytoma | 1 | 1993 | 22 | 0.030 |
Why?
|
Adrenal Gland Neoplasms | 1 | 1993 | 26 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2014 | 40 | 0.030 |
Why?
|
Phosphorylation | 1 | 2017 | 1200 | 0.030 |
Why?
|
Debridement | 1 | 1993 | 55 | 0.030 |
Why?
|
Lipids | 1 | 2015 | 298 | 0.030 |
Why?
|
Colectomy | 1 | 1994 | 64 | 0.030 |
Why?
|
Cystic Duct | 1 | 1993 | 5 | 0.030 |
Why?
|
Bile Duct Diseases | 1 | 1993 | 28 | 0.030 |
Why?
|
Viscera | 1 | 1993 | 16 | 0.030 |
Why?
|
Cell Differentiation | 1 | 2017 | 1034 | 0.030 |
Why?
|
Necrosis | 1 | 1994 | 239 | 0.030 |
Why?
|
Vascular Diseases | 2 | 1990 | 94 | 0.030 |
Why?
|
Surgery Department, Hospital | 1 | 1993 | 19 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2014 | 148 | 0.030 |
Why?
|
Sex Factors | 1 | 2016 | 1266 | 0.030 |
Why?
|
Mice, Inbred DBA | 1 | 2012 | 120 | 0.030 |
Why?
|
Alcoholism | 1 | 2001 | 1109 | 0.030 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2012 | 236 | 0.030 |
Why?
|
Hospitals, University | 1 | 1993 | 169 | 0.030 |
Why?
|
Punctures | 1 | 1992 | 35 | 0.030 |
Why?
|
Arteries | 1 | 1993 | 108 | 0.030 |
Why?
|
DNA, Neoplasm | 1 | 1992 | 95 | 0.030 |
Why?
|
Radiography, Interventional | 1 | 1992 | 49 | 0.030 |
Why?
|
Disease Models, Animal | 2 | 2015 | 2550 | 0.020 |
Why?
|
Intestine, Small | 2 | 2004 | 89 | 0.020 |
Why?
|
Disaster Planning | 1 | 1993 | 105 | 0.020 |
Why?
|
Urinary Bladder | 1 | 1991 | 108 | 0.020 |
Why?
|
Contraindications | 1 | 1990 | 52 | 0.020 |
Why?
|
Ethanol | 1 | 2017 | 893 | 0.020 |
Why?
|
Rectal Neoplasms | 1 | 2011 | 75 | 0.020 |
Why?
|
Gastroscopy | 1 | 1991 | 45 | 0.020 |
Why?
|
Surgical Flaps | 1 | 1991 | 120 | 0.020 |
Why?
|
Embolization, Therapeutic | 1 | 1993 | 150 | 0.020 |
Why?
|
New Zealand | 1 | 1990 | 28 | 0.020 |
Why?
|
Spain | 1 | 1990 | 34 | 0.020 |
Why?
|
Disasters | 1 | 1993 | 204 | 0.020 |
Why?
|
Anemia, Pernicious | 1 | 1990 | 11 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2014 | 396 | 0.020 |
Why?
|
Carcinoid Tumor | 1 | 1990 | 20 | 0.020 |
Why?
|
HIV Seropositivity | 1 | 1990 | 66 | 0.020 |
Why?
|
Multiple Trauma | 1 | 2010 | 50 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 1293 | 0.020 |
Why?
|
Injury Severity Score | 1 | 2010 | 204 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 1990 | 124 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2014 | 617 | 0.020 |
Why?
|
Calcinosis | 1 | 1991 | 241 | 0.020 |
Why?
|
Mesenteric Vascular Occlusion | 1 | 1989 | 20 | 0.020 |
Why?
|
Portal Vein | 1 | 1989 | 46 | 0.020 |
Why?
|
Biopsy | 1 | 2010 | 540 | 0.020 |
Why?
|
Cuba | 1 | 1988 | 8 | 0.020 |
Why?
|
Ultrasonography | 1 | 2010 | 453 | 0.020 |
Why?
|
Amputation, Traumatic | 1 | 1988 | 11 | 0.020 |
Why?
|
History, 21st Century | 1 | 2008 | 127 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2016 | 4848 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2007 | 33 | 0.020 |
Why?
|
Fiber Optic Technology | 1 | 1986 | 40 | 0.020 |
Why?
|
Pacemaker, Artificial | 1 | 2007 | 157 | 0.020 |
Why?
|
Forecasting | 1 | 2007 | 277 | 0.020 |
Why?
|
Fibrosis | 1 | 2007 | 371 | 0.020 |
Why?
|
Military Personnel | 1 | 1988 | 221 | 0.020 |
Why?
|
Liver Extracts | 1 | 2004 | 1 | 0.020 |
Why?
|
Centrifugation, Density Gradient | 1 | 2004 | 36 | 0.020 |
Why?
|
Gallbladder | 1 | 2004 | 15 | 0.020 |
Why?
|
Sucrose | 1 | 2004 | 58 | 0.020 |
Why?
|
Iohexol | 1 | 2004 | 82 | 0.010 |
Why?
|
Electrocardiography | 1 | 2007 | 601 | 0.010 |
Why?
|
Stroke Volume | 1 | 2007 | 586 | 0.010 |
Why?
|
Ventricular Remodeling | 1 | 2007 | 318 | 0.010 |
Why?
|
History, 16th Century | 1 | 1983 | 8 | 0.010 |
Why?
|
Europe | 1 | 1983 | 196 | 0.010 |
Why?
|
Hemostatic Techniques | 1 | 1999 | 23 | 0.010 |
Why?
|
Administration, Topical | 1 | 1999 | 111 | 0.010 |
Why?
|
Acetylation | 1 | 1999 | 94 | 0.010 |
Why?
|
Postoperative Hemorrhage | 1 | 1999 | 69 | 0.010 |
Why?
|
Spleen | 1 | 1999 | 301 | 0.010 |
Why?
|
Infant | 2 | 1998 | 2891 | 0.010 |
Why?
|
Heart Failure | 1 | 2007 | 1180 | 0.010 |
Why?
|
Swine | 1 | 1999 | 672 | 0.010 |
Why?
|
Child, Preschool | 2 | 1998 | 3187 | 0.010 |
Why?
|
Sphincter of Oddi | 1 | 1998 | 51 | 0.010 |
Why?
|
Minimally Invasive Surgical Procedures | 1 | 1998 | 85 | 0.010 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 1999 | 185 | 0.010 |
Why?
|
Manometry | 1 | 1998 | 276 | 0.010 |
Why?
|
Dilatation | 1 | 1995 | 58 | 0.010 |
Why?
|
Maintenance and Engineering, Hospital | 1 | 1993 | 3 | 0.010 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1993 | 14 | 0.010 |
Why?
|
Electric Power Supplies | 1 | 1993 | 26 | 0.010 |
Why?
|
Diploidy | 1 | 1992 | 7 | 0.010 |
Why?
|
Trauma Centers | 1 | 1993 | 197 | 0.010 |
Why?
|
Duodenal Obstruction | 1 | 1991 | 2 | 0.010 |
Why?
|
Pyloric Stenosis | 1 | 1991 | 5 | 0.010 |
Why?
|
Gastroenterostomy | 1 | 1991 | 8 | 0.010 |
Why?
|
Flow Cytometry | 1 | 1992 | 489 | 0.010 |
Why?
|
Somatostatin | 1 | 1989 | 36 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 1990 | 64 | 0.010 |
Why?
|
Mesenteric Veins | 1 | 1989 | 10 | 0.010 |
Why?
|
Radiography | 1 | 1989 | 572 | 0.000 |
Why?
|